Scientific Interest and Research Findings The increased scientific literature on BPC157 has grown over the last few years
Disclosure Fernando Gomez-Peralta has received research support from Sanofi, Novo Nordisk, Boehringer Ingelheim, and Eli Lilly, has taken part in advisory boards for Sanofi, Novo Nordisk, and AstraZeneca Pharmaceuticals LP, and has acted as a speaker for Sanofi, Novo Nordisk, Boehringer Ingelheim, Novartis, Bristol-Myers Squibb Company, Eli Lilly, and AstraZeneca Pharmaceuticals LP
Most compounded GLP-1s were paid for in cash and are often prescribed outside of traditional clinical settings, such as weight loss clinics or telehealth platforms
2019;94(3):E7880
Jeeli kto mimo wszystko rozwaa stosowanie BPC-157, rozsdnym minimum przed rozpoczciem jest wykonanie podstawowych bada kontrolnych